182 related articles for article (PubMed ID: 38095671)
1. A convolutional neural network-based system for fully automatic segmentation of whole-body [
Jafari E; Zarei A; Dadgar H; Keshavarz A; Manafi-Farid R; Rostami H; Assadi M
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1476-1487. PubMed ID: 38095671
[TBL] [Abstract][Full Text] [Related]
2. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [
Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Ebert MA
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):67-79. PubMed ID: 35976392
[TBL] [Abstract][Full Text] [Related]
3. Deep learning-based whole-body characterization of prostate cancer lesions on [
Huang B; Yang Q; Li X; Wu Y; Liu Z; Pan Z; Zhong S; Song S; Zuo C
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1173-1184. PubMed ID: 38049657
[TBL] [Abstract][Full Text] [Related]
4. Automated segmentation of lesions and organs at risk on [
Yazdani E; Karamzadeh-Ziarati N; Cheshmi SS; Sadeghi M; Geramifar P; Vosoughi H; Jahromi MK; Kheradpisheh SR
Cancer Imaging; 2024 Feb; 24(1):30. PubMed ID: 38424612
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
[TBL] [Abstract][Full Text] [Related]
7. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss.
Xu Y; Klyuzhin I; Harsini S; Ortiz A; Zhang S; Bénard F; Dodhia R; Uribe CF; Rahmim A; Lavista Ferres J
Comput Biol Med; 2023 May; 158():106882. PubMed ID: 37037147
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
9. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
10. Whole-body uptake classification and prostate cancer staging in
Capobianco N; Sibille L; Chantadisai M; Gafita A; Langbein T; Platsch G; Solari EL; Shah V; Spottiswoode B; Eiber M; Weber WA; Navab N; Nekolla SG
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):517-526. PubMed ID: 34232350
[TBL] [Abstract][Full Text] [Related]
11. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using
Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484
[TBL] [Abstract][Full Text] [Related]
12. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
Aksu A; Vural Topuz Ö; Yılmaz G; Çapa Kaya G; Yılmaz B
Ann Nucl Med; 2022 Mar; 36(3):310-318. PubMed ID: 34988888
[TBL] [Abstract][Full Text] [Related]
13. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
14. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [
Lv J; Yu H; Yin H; Shi Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684
[TBL] [Abstract][Full Text] [Related]
15. Impact of uptake time on image quality of [
van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
[TBL] [Abstract][Full Text] [Related]
16.
Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716
[TBL] [Abstract][Full Text] [Related]
17. [
Xie Y; Li C; Zhang L; Zang S; Yu F; Wang S; Wang F
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1143-1148. PubMed ID: 36073212
[TBL] [Abstract][Full Text] [Related]
18. Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [
Kluge K; Einspieler H; Haberl D; Spielvogel C; Stoiber S; Vraka C; Papp L; Wunsch S; Egger G; Kramer G; Grubmüller B; Shariat S; Hacker M; Kenner L; Haug A
J Nucl Med; 2024 Jan; 65(1):63-70. PubMed ID: 38050125
[TBL] [Abstract][Full Text] [Related]
19. Deep neural network for automatic characterization of lesions on
Zhao Y; Gafita A; Vollnberg B; Tetteh G; Haupt F; Afshar-Oromieh A; Menze B; Eiber M; Rominger A; Shi K
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):603-613. PubMed ID: 31813050
[TBL] [Abstract][Full Text] [Related]
20. Prospective Evaluation of
Lopci E; Lughezzani G; Castello A; Saita A; Colombo P; Hurle R; Peschechera R; Benetti A; Zandegiacomo S; Pasini L; Casale P; Pietro D; Bevilacqua G; Balzarini L; Buffi NM; Guazzoni G; Lazzeri M
Eur Urol Focus; 2021 Jul; 7(4):764-771. PubMed ID: 32312701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
